69002-85-3

Basic information

• Product Name: [2-(2,6-Dichloro-3-hydroxyanilino)phenyl]acetic acid
• Synonyms: [2-(2,6-Dichloro-3-hydroxyanilino)phenyl]acetic acid;2-(2,6-Dichloro-3-hydroxyphenylamino)benzeneacetic acid;3'-Hydroxydiclofenac
• CAS NO: 69002-85-3
• Molecular Formula: C₁₄H₁₁Cl₂NO₃
• Molecular Weight: 312.14804
• Mol File: 69002-85-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 159-162 °C
• Boiling Point: 429.5°Cat760mmHg
• Flash Point: 213.5°C
• Appearance: /
• Density: 1.52g/cm³
• Vapor Pressure: 3.86E-08mmHg at 25°C
• Refractive Index: 1.689
• PKA: 4.17±0.10(Predicted)
• CAS DataBase Reference: [2-(2,6-Dichloro-3-hydroxyanilino)phenyl]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(2,6-Dichloro-3-hydroxyanilino)phenyl]acetic acid(69002-85-3)
• EPA Substance Registry System: [2-(2,6-Dichloro-3-hydroxyanilino)phenyl]acetic acid(69002-85-3)

Safety Data

• Hazardous Substances Data: 69002-85-3(Hazardous Substances Data)

Usage

Uses

3’-Hydroxy Diclofenac is a metabolite of Diclofenac (D436450), a nonsteroidal anti-inflammatory compound and a cyclooxygenase (COX) inhibitor (1,2,3). Diclofenac exhibits anti-inflammatory, analgesic, and antipyretic properties.

Definition

ChEBI: An organochlorine compound that is the 3'-hydroxylated metabolite of diclofenac.

InChI:InChI=1/C14H11Cl2NO3/c15-9-5-6-11(18)13(16)14(9)17-10-4-2-1-3-8(10)7-12(19)20/h1-6,17-18H,7H2,(H,19,20)

Upstream product

• 245732-71-2 1-(2,6-Dichloro-3-hydroxy-phenyl)-1,3-dihydro-indol-2-one 
• 15307-79-6 diclofenac sodium 
• 245732-68-7 N-phenyl-2,6-dichloro-3-nitroaniline 
• 15307-86-5 [2-(2,6-dichloroanilino)phenyl]acetic acid 
• 127792-26-1 [2-(2,6-Dichloro-3-methoxy-phenylamino)-phenyl]-acetic acid 
• 1618-54-8 (2,6-Dichloro-3-methoxy-phenyl)-phenyl-amine 
• 13785-48-3 2,6-dichloro-3-nitroaniline 
• 245732-69-8 1,3-dihydro-N-[(2,6-dichloro-3-nitro)phenyl]-2H-indol-2,3-dione 
• 245732-70-1 1,3-dihydro-N-[(2,6-dichloro-3-amino)phenyl]-2H-indol-2-one 

Relevant articles and documents

CYP267A1 and CYP267B1 from sorangium cellulosum so ce56 are highly versatile drug metabolizers

The guidelines of the Food and Drug Administration and International Conference on Harmonization have highlighted the importance of drug metabolites in clinical trials. As a result, an authentic source for their production is of great interest, both for t

Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways

The aim of this study was to re-examine the human hepatic metabolism of diclofenac, with special focus on the generation of minor hydroxylated metabolites implicated in the idiosyncratic hepatotoxicity of the drug. Different experimental approaches were u